China National Medicines Corporation Ltd.

Shanghai Stock Exchange 600511.SS

China National Medicines Corporation Ltd. Capital Expenditure for the year ending December 31, 2023: USD -20.44 M

China National Medicines Corporation Ltd. Capital Expenditure is USD -20.44 M for the year ending December 31, 2023, a -8.69% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

China National Medicines Corporation Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -18.81 M, a -25.70% change year over year.
China National Medicines Corporation Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -14.96 M, a -41.43% change year over year.
China National Medicines Corporation Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -10.58 M, a 14.06% change year over year.
China National Medicines Corporation Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -12.31 M, a 36.09% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shanghai Stock Exchange: 600511.SS

China National Medicines Corporation Ltd.

CEO	Mr. Guotao Tian
IPO Date	Nov. 27, 2002
Location	China
Headquarters	No. 12 A, Sanyuan West Alley
Employees	3,138
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

Key trends

Past 5 years